PROGRESS IN STEM CELL

Indexed and abstracted by Pubmed (Selected citation only), Scopus, Embase, Google Scholar

Skip to main content Skip to main navigation menu Skip to site footer

 Editorials

HTML

1593

Total

180

Share

Welcome to Progress in Stem Cell





 Open Access   

Abstract

Welcome to the new open access journal Progress in Stem Cell, edited by Dr. Phuc Van Pham, and Dr. Ngoc Kim Phan, of Vietnam National University, Ho Chi Minh city, Vietnam. Progress in Stem Cell (ISSN 2199-4633) is the Open Access journal that acts as a forum for translational research into stem cell therapies. Progress in Stem Cell is scientific journal that overlays the study of cancer stem cells, stem cell therapy, stem-cell transplantation, human embryonic stem cells, neural stem cells, murine embryonic stem cells, adult stem cell... Progress in Stem Cell is a peer-reviewed journal that focuses on the areas of established and emerging concepts in stem cell research and their assorted disease therapies. It provides an opportunity to share the scientific information among the clinical & medical scientists and researchers. Progress in Stem Cell publishes the most complete and reliable source of information on the discoveries and current developments in the mode of editorial, original research, review, commentary, letter in all areas of stem cell from basic research to pre-clinical trials and clinical trials.

Why is stem cell research important?

Stem cell science has great potential in the regenerative medicine as well as others such as biology development, pharmacology, agriculture… Stem cell research helps to explain some important mechanisms of reproduction, growth, aging and disease. Stem cell therapy is a promising therapy for degenerative diseases included Huntington disease Choi et al., 2014a , Parkinson Bjorklund and Kordower, 2013 , Alzheimer disease Choi et al., 2014b … alternatively, chronic disease included cardiac failure Michler, 2014 , diabetes Calne et al., 2013 , osteoarthritis Jorgensen, 2013 …

In fact, stem cells hold wonderful characteristics included self-renewal that can maintain the proliferation for a long time and differentiation that can produce specialized cells. To date, stem cells successfully isolated from a lot of different sources in the human body as well as the placenta and umbilical cord. Recently, pluripotent stem cells can be produced by reprogramming of adult somatic cells Takahashi and Yamanaka, 2006 . With this technique, stem cell research is added by powerful tool for stem cell production and modification.

After more than 20 years that human embryonic stem cell was successfully isolated and cultured by James Thomson stem cells have studied and applied in a wide range of medicine Thomson et al., 1998 . Stem cell can be used as drugs in disease treatments such as autoimmune disease Zheng et al., 2013 , osteoarthritis Van Pham et al., 2014 , diabetes mellitus Viswanathan and Sarang, 2013 , non-healing ulcer Tran et al., 2014 … Stem cell also used in stem cell gene therapy to correct some gene mutations, or in tissue engineering.

More interesting, stem cells based drugs have been approved by FDA in some countries such as Prochymal (Canada), HemaCord (USA), Ducord (USA), Cartistem (Korea)…

Publish with Progress in Stem Cell

Progress in Stem Cell will publish almost of article types included research articles, commentaries, corrections, editorials, letters, and reviews. All manuscripts must be gone to double-blind peer-review process. The first decision after submitting is 1-2 weeks. All manuscripts will be check plagiarism by the crosscheck and grammarly software.

We have been delighted by the support of Springer International Publisher. Progress in Stem Cell is hosted by Global Science Journal (GSJ), Springer. GSJ uses the same technology of Springer to publish an international journal. With Springer technology, all articles will weekly be updated as Springerlink ensuring that they are always state of the art, optimize for maximum findability by internet Search Engine algorithms.

Moreover, from first issue journal will be sent for evaluation at popular databases included SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, DOAJ, ISI, PubMed/Medline, Pubmed Central.

We welcome your contributions

Progress in Stem Cell will provide a new platform for translational research into stem cell therapy. The Editors-in-Chief, supported by a global Editorial Board, are committed to making this journal a success, and we look forward to receiving your contributions. We hope, too, that it will inspire you to send us your next manuscript and choose Progress in Stem Cell as the host for your publications.

References

  1. A. Bjorklund, J.H. Kordower. Cell therapy for Parkinson's disease: what next?. Movement disorders : official journal of the Movement Disorder Society. 2013;28:110-115. Google Scholar
  2. R.Y. Calne, M.A. Ghoneim, K.O. Lee, G.S. Uin. Gene and stem cell therapy for diabetes. Clinical transplants. 2013;:111-112. Google Scholar
  3. K.A. Choi, I. Hwang, H.S. Park, S.I. Oh, S. Kang, S. Hong. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease. Biotechnology journal. 2014a;9:882-894. Google Scholar
  4. S.S. Choi, S.R. Lee, S.U. Kim, H.J. Lee. Alzheimer's disease and stem cell therapy. Experimental neurobiology. 2014b;23:45-52. Google Scholar
  5. C. Jorgensen. Mesenchymal stem cells: uses in osteoarthritis. Joint, bone, spine : revue du rhumatisme. 2013;80:565-567. Google Scholar
  6. R.E. Michler. Stem cell therapy for heart failure. Cardiology in review. 2014;22:105-116. Google Scholar
  7. K. Takahashi, S. Yamanaka. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676. Google Scholar
  8. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones. Embryonic stem cell lines derived from human blastocysts. Science (New. 1998;York:NY) 282, 1145-1147. Google Scholar
  9. T.D.-X. Tran, P.T.-B. Le, P. Van Pham. Diabetic foot ulcer treatment by activated platelet rich plasma: a clinical study. Biomed Res Ther. 2014;1:1-6. Google Scholar
  10. P. Van Pham. Welcome to Biomedical Research and Therapy. Biomed Res Ther. 2014;1:1-1. Google Scholar
  11. P. Van Pham, K.H.-T. Bui, T.D. Duong, N.T. Nguyen, T.D. Nguyen, V.T. Le, V.T. Mai, N.L.-C. Phan, D.M. Le, N.K. Ngoc. Symptomatic knee osteoarthritis treatment using autologous adipose derived stem cells and platelet-rich plasma: a clinical study. Biomed Res Ther. 2014;1:1-7. Google Scholar
  12. C. Viswanathan, S. Sarang. Status of stem cell based clinical trials in the treatment for diabetes. Current diabetes reviews. 2013;9:429-436. Google Scholar
  13. G.P. Zheng, M.H. Ge, Q. Shu, M. Rojas, J. Xu. Mesenchymal stem cells in the treatment of pediatric diseases. World journal of pediatrics : WJP. 2013;9:197-211. Google Scholar

Downloads

Download data is not yet available.


Author's Affiliation
Article Details

Issue: Vol 1 No 01 (2014): Running Issue
Page No.: 1-2
Published: Aug 15, 2014
Section: Editorials
DOI:

 Copyright Info

Creative Commons License

Copyright: The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 How to Cite
Pham, P., & Phan, N. (2014). Welcome to Progress in Stem Cell. Progress in Stem Cell, 1(01), 1-2. Retrieved from http://www.cellstemcell.org/index.php/PSC/article/view/114

 Cited by

Article level Metrics by Paperbuzz/Impactstory
Article level Metrics by Altmetrics

 Article Statistics
HTML = 1593 times
Download PDF   = 163 times
View Article   = 17 times
Total   = 180 times